Skip to main content

Advertisement

Log in

Human Papillomavirus and Epstein Barr Virus in Head and Neck Carcinomas: Suggestions for the New WHO Classification

  • Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 2, 2014, San Diego, California
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

In the 9 years since the last World Health Organization (WHO) classification for head and neck tumors, a great deal has changed. In particular, human papillomavirus (HPV) has emerged as the major etiologic agent and patient prognostic marker for squamous cell carcinoma, most profoundly in the oropharynx. It also casts a long shadow over all of the rest of head and neck cancer given its biologic and prognostic implications. By contrast, little has changed regarding our knowledge of Epstein–Barr virus in head and neck cancers, except as it relates to HPV in nonkeratinizing-type nasopharyngeal carcinomas. This article discusses some of the major advances in our understanding of virus-related squamous cell carcinoma of the head and neck and suggests several specific concepts and terminology for incorporation into the next WHO classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Johnson N, Francheschi S, Ferlay J, et al. Squamous cell carcinoma of the oral cavity and oropharynx. In: Barnes EL, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours—pathology and genetics head and neck tumours. Lyon: IARC Press; 2005. p. 168–75.

    Google Scholar 

  2. Wu X, Watson M, Wilson R, et al. Human papillomavirus-associated cancers—United States, 2004–2008. Morb Mortal Wkly Rep. 2012;61(15):258–61.

    Google Scholar 

  3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22(2):128–42.

    Article  PubMed  Google Scholar 

  6. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36(7):945–54.

    Article  PubMed  Google Scholar 

  7. Ukpo OC, Flanagan JJ, Ma XJ, et al. High risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35(9):1343–50.

    Article  PubMed  Google Scholar 

  8. Robinson M, Schache A, Sloan P, et al. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 2012;6(Suppl 1):S83–90.

    Article  PubMed  Google Scholar 

  9. Robinson M, Sloan P, Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol. 2010;46(7):492–6.

    Article  PubMed  Google Scholar 

  10. Lewis JS Jr. p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6(Suppl 1):75–82.

    Article  PubMed Central  Google Scholar 

  11. Rietbergen MM, Brakenhoff RH, Bloemena E et al. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials. Ann Oncol. 2013;24(11):2740–5.

    Google Scholar 

  12. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):339–45.

    Article  PubMed  Google Scholar 

  13. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3(3):186–94.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Chernock RD, Lewis JS Jr, Zhang Q, et al. Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol. 2010;41(7):1016–23.

    Article  CAS  PubMed  Google Scholar 

  15. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32(7):1044–50.

    Article  PubMed  Google Scholar 

  16. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33(11):1720–4.

    Article  PubMed  Google Scholar 

  17. Mehrad M, Carpenter DH, Chernock RD, et al. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol. 2013;37(9):1349–56.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Carpenter DH, El-Mofty SK, Lewis JS Jr. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis. Mod Pathol. 2011;24(10):1306–12.

    Article  CAS  PubMed  Google Scholar 

  19. Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34(6):800–5.

    Article  PubMed  Google Scholar 

  20. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5(2):108–16.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Lewis JS Jr, Scantlebury JB, Luo J, et al. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers. Am J Surg Pathol. 2012;36(7):1036–46.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat. 1994;185(Pt 1):111–27.

    PubMed Central  PubMed  Google Scholar 

  23. Westra WH. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 2012;6(Suppl 1):S48–54.

    Article  PubMed  Google Scholar 

  24. Park GC, Lee M, Roh JL, et al. Human papillomavirus and p16 detection in cervical lymph node metastases from an unknown primary tumor. Oral Oncol. 2012;48(12):1250–6.

    Article  CAS  PubMed  Google Scholar 

  25. Dogan S, Hedberg ML, Ferris RL et al. Human papillomavirus and Epstein–Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2013. doi:10.1002/hed.23318.

  26. Maxwell JH, Kumar B, Feng FY, et al. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck. 2010;32(5):562–7.

    PubMed Central  PubMed  Google Scholar 

  27. Robinson M, Suh YE, Paleri V, et al. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agent Cancer. 2013;8(1):30.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Chan JKC, Bray F, McCarron P, et al. Nasopharyngeal Carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours—pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005. p. 85–97.

    Google Scholar 

  29. Lo EJ, Bell D, Woo J, et al. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope. 2011;120(Suppl 4):S185.

    Google Scholar 

  30. Punwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein–Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck. 1999;21(1):21–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Samir K. El-Mofty DMD, PhD, for his longtime friendship, support of our careers in head and neck pathology, and particularly for inciting our interest in HPV-related tumors. The authors also thank Jingqin (Rosy) Luo, PhD, for the survival analysis and Kaplan–Meier survival curves shown in Fig. 3 on the patients in the authors’ research database, and thank Brian Nussenbaum MD and Wade L. Thorstad MD for their input on the clinical perspectives on treatment of HPV-related oropharyngeal SCC patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James S. Lewis Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, J.S., Chernock, R.D. Human Papillomavirus and Epstein Barr Virus in Head and Neck Carcinomas: Suggestions for the New WHO Classification. Head and Neck Pathol 8, 50–58 (2014). https://doi.org/10.1007/s12105-014-0528-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-014-0528-6

Keywords

Navigation